An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
Condition(s):Opioid-use DisorderLast Updated:October 3, 2022Completed
Condition(s):Opioid Use Disorder, Severe; Opioid Use Disorder, ModerateLast Updated:February 11, 2021Completed
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
Condition(s):Opioid Use DisorderLast Updated:March 27, 2024Completed
Condition(s):Opioid Use DisorderLast Updated:February 29, 2024Withdrawn
Condition(s):Opioid-use DisorderLast Updated:March 24, 2020Withdrawn
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:February 11, 2022Completed
Condition(s):Moderate to Severe Opioid Use DisorderLast Updated:October 26, 2022Not yet recruiting
Condition(s):Opioid-use DisorderLast Updated:February 2, 2024Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.